Latest Breaking News On - Protagonist therapeutics daily - Page 1 : comparemela.com

Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Get Free Report) Director William D. Waddill sold 8,000 shares of the firm’s stock in a transaction dated Friday, June 7th. The shares were sold at an average price of $35.00, for a total transaction of $280,000.00. Following the completion of the transaction, the director now directly owns 12,000 shares […]

United statesZurcher kantonalbank zurich cantonalbankWilliamd waddillPrincipal financial group incProtagonist therapeutics incBoard of administration florida retirement systemHennion walsh asset management incProshare advisorsJpmorgan chase coProtagonist therapeuticsGet free reportDirector williamWalsh asset managementFlorida retirement systemFinancial groupKantonalbank zurich cantonalbank